Matches in SemOpenAlex for { <https://semopenalex.org/work/W2760767555> ?p ?o ?g. }
- W2760767555 endingPage "107" @default.
- W2760767555 startingPage "100" @default.
- W2760767555 abstract "The objective of this study was to evaluate the effect of pharmacogenetics-guided treatment on patients diagnosed with depression and/or anxiety, in a diverse set of clinical settings, as compared to the standard of care. The trial design followed a prospective, randomized, subject- and rater-blinded approach enrolling 685 patients from clinical providers specializing in Psychiatry, Internal Medicine, Obstetrics & Gynecology, and Family Medicine. The NeuroIDgenetix® test uses a genetic variant panel of ten genes, along with concomitant medications, to make medication management recommendations based on gene-drug and drug-drug interactions for over 40 medications used in the treatment of depression and anxiety. Pharmacogenetic testing was performed at the initial screening visit and baseline patient assessments were determined using the 17-item Hamilton Rating Scale for Depression (HAM-D17) and the Hamilton Rating Scale for Anxiety (HAM-A). Following enrollment and randomization, pharmacogenetic results for subjects assigned to the experimental group were provided to physicians to guide treatment selection, while control subjects were treated according to the usual standard of care. HAM-D17 and HAM-A assessments were collected at 4 weeks, 8 weeks, and 12 weeks after baseline to assess the efficacy of therapeutic selection. In patients diagnosed with depression, response rates (p = 0.001; OR: 4.72 [1.93-11.52]) and remission rates (p = 0.02; OR: 3.54 [1.27-9.88]) were significantly higher in the pharmacogenetics-guided group as compared to the control group at 12 weeks. In addition, patients in the experimental group diagnosed with anxiety showed a meaningful improvement in HAM-A scores at both 8 and 12 weeks (p = 0.02 and 0.02, respectively), along with higher response rates (p = 0.04; OR: 1.76 [1.03-2.99]). From these results, we conclude that pharmacogenetic-guided medication selection significantly improves outcomes of patients diagnosed with depression or anxiety, in a variety of healthcare settings." @default.
- W2760767555 created "2017-10-06" @default.
- W2760767555 creator A5007452064 @default.
- W2760767555 creator A5009979752 @default.
- W2760767555 creator A5020305661 @default.
- W2760767555 creator A5040645703 @default.
- W2760767555 creator A5053358394 @default.
- W2760767555 creator A5059555537 @default.
- W2760767555 creator A5081649967 @default.
- W2760767555 creator A5083182158 @default.
- W2760767555 creator A5083403270 @default.
- W2760767555 creator A5084041245 @default.
- W2760767555 date "2018-01-01" @default.
- W2760767555 modified "2023-10-02" @default.
- W2760767555 title "Improved efficacy with targeted pharmacogenetic-guided treatment of patients with depression and anxiety: A randomized clinical trial demonstrating clinical utility" @default.
- W2760767555 cites W1967031549 @default.
- W2760767555 cites W2003385727 @default.
- W2760767555 cites W2004241099 @default.
- W2760767555 cites W2024913341 @default.
- W2760767555 cites W2039056175 @default.
- W2760767555 cites W2063280109 @default.
- W2760767555 cites W2069365138 @default.
- W2760767555 cites W2076675985 @default.
- W2760767555 cites W2102151931 @default.
- W2760767555 cites W2104275147 @default.
- W2760767555 cites W2106095564 @default.
- W2760767555 cites W2108182085 @default.
- W2760767555 cites W2114613490 @default.
- W2760767555 cites W2118826874 @default.
- W2760767555 cites W2124289434 @default.
- W2760767555 cites W2132324173 @default.
- W2760767555 cites W2143110843 @default.
- W2760767555 cites W2146659162 @default.
- W2760767555 cites W2149402043 @default.
- W2760767555 cites W2160070901 @default.
- W2760767555 cites W2161620765 @default.
- W2760767555 cites W2168124527 @default.
- W2760767555 cites W2254462287 @default.
- W2760767555 cites W2321809087 @default.
- W2760767555 cites W4293258603 @default.
- W2760767555 doi "https://doi.org/10.1016/j.jpsychires.2017.09.024" @default.
- W2760767555 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/28992526" @default.
- W2760767555 hasPublicationYear "2018" @default.
- W2760767555 type Work @default.
- W2760767555 sameAs 2760767555 @default.
- W2760767555 citedByCount "131" @default.
- W2760767555 countsByYear W27607675552017 @default.
- W2760767555 countsByYear W27607675552018 @default.
- W2760767555 countsByYear W27607675552019 @default.
- W2760767555 countsByYear W27607675552020 @default.
- W2760767555 countsByYear W27607675552021 @default.
- W2760767555 countsByYear W27607675552022 @default.
- W2760767555 countsByYear W27607675552023 @default.
- W2760767555 crossrefType "journal-article" @default.
- W2760767555 hasAuthorship W2760767555A5007452064 @default.
- W2760767555 hasAuthorship W2760767555A5009979752 @default.
- W2760767555 hasAuthorship W2760767555A5020305661 @default.
- W2760767555 hasAuthorship W2760767555A5040645703 @default.
- W2760767555 hasAuthorship W2760767555A5053358394 @default.
- W2760767555 hasAuthorship W2760767555A5059555537 @default.
- W2760767555 hasAuthorship W2760767555A5081649967 @default.
- W2760767555 hasAuthorship W2760767555A5083182158 @default.
- W2760767555 hasAuthorship W2760767555A5083403270 @default.
- W2760767555 hasAuthorship W2760767555A5084041245 @default.
- W2760767555 hasBestOaLocation W27607675551 @default.
- W2760767555 hasConcept C104317684 @default.
- W2760767555 hasConcept C118552586 @default.
- W2760767555 hasConcept C126322002 @default.
- W2760767555 hasConcept C135763542 @default.
- W2760767555 hasConcept C139719470 @default.
- W2760767555 hasConcept C162324750 @default.
- W2760767555 hasConcept C168563851 @default.
- W2760767555 hasConcept C185592680 @default.
- W2760767555 hasConcept C1862650 @default.
- W2760767555 hasConcept C204243189 @default.
- W2760767555 hasConcept C2776466505 @default.
- W2760767555 hasConcept C2776867660 @default.
- W2760767555 hasConcept C2780051608 @default.
- W2760767555 hasConcept C2780733359 @default.
- W2760767555 hasConcept C535046627 @default.
- W2760767555 hasConcept C55493867 @default.
- W2760767555 hasConcept C55775858 @default.
- W2760767555 hasConcept C558461103 @default.
- W2760767555 hasConcept C71924100 @default.
- W2760767555 hasConceptScore W2760767555C104317684 @default.
- W2760767555 hasConceptScore W2760767555C118552586 @default.
- W2760767555 hasConceptScore W2760767555C126322002 @default.
- W2760767555 hasConceptScore W2760767555C135763542 @default.
- W2760767555 hasConceptScore W2760767555C139719470 @default.
- W2760767555 hasConceptScore W2760767555C162324750 @default.
- W2760767555 hasConceptScore W2760767555C168563851 @default.
- W2760767555 hasConceptScore W2760767555C185592680 @default.
- W2760767555 hasConceptScore W2760767555C1862650 @default.
- W2760767555 hasConceptScore W2760767555C204243189 @default.
- W2760767555 hasConceptScore W2760767555C2776466505 @default.
- W2760767555 hasConceptScore W2760767555C2776867660 @default.
- W2760767555 hasConceptScore W2760767555C2780051608 @default.
- W2760767555 hasConceptScore W2760767555C2780733359 @default.